News from duchesnay usa A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 20, 2019, 09:00 ET Duchesnay USA launches three videos featuring gynecologist and menopause care specialist, Dr. Barb DePree

ROSEMONT, PA, Aug. 20, 2019 /PRNewswire/ - Duchesnay USA, a pharmaceutical company that specializes in women's health, is pleased to announce the...


Aug 13, 2019, 09:00 ET Duchesnay USA announces the launch of a new Osphena® (ospemifene) website

ROSEMONT, PA, Aug. 13, 2019 /PRNewswire/ - Duchesnay USA, a pharmaceutical company that specializes in women's health, is pleased to announce the...


Jul 08, 2019, 10:00 ET National Survey Launched to Identify Key Health Concerns Facing Menopausal Women

Duchesnay USA and FabOverFifty.com Join Forces to Elevate the Conversation Surrounding Menopause ROSEMONT, PA, July 8, 2019 /PRNewswire/ - Duchesnay...


Jun 05, 2019, 15:00 ET Effects of Ospemifene on Genitourinary Health: Prospective Vulvar-Vestibular Photography and Direct Assessments in Post-Menopausal Women

ROSEMONT, PA, June 5, 2019 /PRNewswire/ - Duchesnay Inc., a pharmaceutical company specializing in women's health, is pleased to announce the...


Jan 29, 2019, 06:00 ET Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Osphena® (ospemifene)

BLAINVILLE, QC, Jan. 29, 2019 /PRNewswire/ - Duchesnay Inc., a pharmaceutical company specializing in women's health, announced today that the FDA...


Oct 29, 2018, 09:00 ET Duchesnay USA, Maker of Osphena®, Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D

ROSEMONT, PA, Oct. 29, 2018 /PRNewswire/ - Duchesnay USA commends the clarification by the Centers for Medicare and Medicaid Services (CMS) of the...


Oct 16, 2018, 09:00 ET Duchesnay USA Continues the Morning Sickness Conversation with Actress, Mom and Singer Jana Kramer and Beverly Hills Ob/Gyn Dr. Jay Goldberg

- Celebrity and her doctor join forces to stress the importance of communication between patients and healthcare providers - ROSEMONT, PA, Oct. 16,...


Jun 25, 2018, 09:42 ET Actress, Mom and Singer Jana Kramer is Expecting and Again Partnering with Duchesnay USA to Spread the Word about Bonjesta® a Newly Formulated Morning Sickness Treatment

Duchesnay USA, a pharmaceutical company specializing in women's health, has announced today its continued partnership with actress, mom and singer...


May 24, 2017, 09:30 ET Duchesnay USA Partners with David and Christina Arquette to Shine a Spotlight on a Safe and Effective Morning Sickness Treatment [1,2]

Actor David Arquette and Wife Encourage Pregnant Women to Not Suffer Silence with Morning Sickness ROSEMONT, PA, May 24, 2017 /PRNewswire/ -...


Apr 18, 2017, 08:00 ET Duchesnay USA Partners with Country Music Singer and Actress Jana Kramer to Raise Awareness about a Safe and Effective Morning Sickness Treatment

Morning Sickness is a Treatable Medical Condition1; Don't Suffer in Silence! ROSEMONT, PA, April 18, 2017 /PRNewswire/ - Duchesnay USA, a specialty...


Jun 28, 2016, 09:00 ET Duchesnay USA Announces Partnership with TV Personality and Expectant Mom Emily Maynard Johnson to Create Awareness about Morning Sickness and Treatment Options

Empowering Women with Morning Sickness: Don't Suffer in Silence Diclegis® (doxylamine succinate/pyridoxine hydrochloride) is the only FDA-approved...


Aug 31, 2015, 08:00 ET Duchesnay USA Publishes Corrective Messaging through Kim Kardashian's Social Media Accounts in Response to FDA's Request

Duchesnay USA announced that it has taken corrective action to address the U.S. Food and Drug Administration's Office of Prescription Drug Promotion...


Jul 20, 2015, 08:00 ET Kim Kardashian West Found Morning Sickness Relief with Diclegis®

Duchesnay USA today expresses appreciation and well wishes to global celebrity Kim Kardashian West who announced on Instagram that she took Diclegis® ...


Jul 09, 2015, 08:00 ET Diclegis® for Morning Sickness Now Available Without Prior Authorization Through Connecticut Fee-For-Service Medicaid Program

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets, for the treatment of Nausea ...


Jul 09, 2015, 08:00 ET Diclegis® for Morning Sickness Now Available Through Humana Pharmacy Solutions

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets for the treatment of Nausea...


Jul 09, 2015, 08:00 ET Diclegis® for Morning Sickness Now Available Through Wisconsin Fee-For-Service Medicaid Program

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets, for the treatment of Nausea ...


Apr 09, 2015, 08:00 ET Diclegis® For Morning Sickness Now Available In Puerto Rico

Duchesnay USA announced today the market introduction of Diclegis® (doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets in...


Apr 09, 2015, 08:00 ET Diclegis® para el malestar matutino ahora disponible en Puerto Rico

Duchesnay USA anunció hoy la introducción en el mercado de Diclegis® (succinato de doxilamina y clorhidrato de piridoxina) tabletas de liberación...


Mar 10, 2015, 08:00 ET Diclegis® for Morning Sickness Now Available Through Aetna's National Coverage Policy

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) for the treatment of Nausea and Vomiting of...


Jan 22, 2015, 08:00 ET Diclegis® for Morning Sickness Now Available Through Texas Fee-For-Service Medicaid Program

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) for the treatment of Nausea and Vomiting of...


Dec 09, 2014, 12:51 ET Duchesnay USA Supports the Food and Drug Administration's (FDA) Decision to Revise System Explaining the Risks of Medicines During Pregnancy

Following more than six years of debate and a panel discussion held in May 2014, the FDA has decided to change how drug companies are required to...


Dec 02, 2014, 08:00 ET Diclegis® for Morning Sickness Now Available Through Tennessee's Fee-For-Service Medicaid Program

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) for the treatment of Nausea and Vomiting of...


Sep 23, 2014, 08:00 ET Diclegis® for Morning Sickness Now Available Through California and Nebraska Fee-For-Service Medicaid Programs

Duchesnay USA today announced that Diclegis® (doxylamine succinate and pyridoxine hydrochloride) for the treatment of Nausea and Vomiting of...


Sep 10, 2014, 12:22 ET Diclegis® (doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg) Available for Pregnant Women With Morning Sickness

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP),[1],[2],[3],[4] more commonly known as morning sickness.[5] ...


Mar 27, 2014, 08:00 ET Duchesnay USA Granted Kosher and Halal Certification for Diclegis® (doxylamine succinate and pyridoxine hydrochloride), the Only FDA-Approved Treatment for Nausea and Vomiting of Pregnancy (NVP)

Duchesnay USA is pleased to announce Kosher and Halal certifications for Diclegis® (doxylamine succinate 10mg and pyridoxine hydrochloride -vitamin...